IQM
15.11.2021 18:46:09 CET | Business Wire | Press release
IQM Quantum Computers has been selected to provide a quantum computing system that will be integrated into an HPC supercomputer to create an accelerator for future scientific research. The delivery is part of a €45.3 million consortium project. The project is funded by the German Federal Ministry of Education and Research (BMBF) with €40.1 million.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211115006110/en/
The highly interdisciplinary consortium with experts from quantum physics and computer science, from research centers and industry, will integrate a quantum computing system provided by IQM into an HPC environment via a research purchase. This will be the first time that a gate-based quantum system will be coupled with an HPC system, making quantum acceleration of HPC applications a reality.
Quantum computers have significant potential for solving a certain class of scientific and industrial problems that cannot be addressed by classical supercomputers. To meet this challenge, HPC centers around the world are looking for ways to integrate quantum accelerators into their computing infrastructure. The ability to provide on-site solutions for quantum computing in conjunction with supercomputers is essential for the development of cutting-edge high-tech solutions from Europe. The main goal of the Q-Exa project is to establish such solutions and thus strengthen the application- related use of quantum technologies from Germany.
IQM will work with Leibniz Supercomputing Centre, LRZ - one of Germany's three national supercomputing centers, Europe's leading HPC and quantum system provider (Atos) and one of Germany's leading innovators of quantum computing applications (HQS) on this project.
Q-Exa's collaborative approach creates strong synergies with other research projects in the German and European ecosystem. The previously announced BMBF project DAQC benefits from novel simulators and fits seamlessly into the concept of the Q-Exa Co-Design Lab. The new Co-Design lab will accelerate the path to self-sustaining quantum computing, the so-called quantum advantage, through industry partnerships. This approach is in line with other German industry efforts, such as the recently formed QUTAC consortium. On the application side, research consortia such as the BMBF projects QLindA , MANIQU and other initiatives support development as industrial use cases can be tested on the Q-Exa demonstrators. Finally, the Q-Exa project supports the European strategy based on integrating quantum computing accelerators into European HPC centers. With Q-Exa, Germany can make an active contribution to these European efforts.
Federal Research Minister Anja Karliczek says: "The international race in the field of quantum technologies is in full swing. Germany and the European Union must do their utmost to keep pace in order to guarantee our technological sovereignty. We want to be able to autonomously use the technology and develop it further. The Q-Exa project opens a new promising chapter on our path to a quantum computer 'made in Germany'. Integrating a quantum computer with the infrastructure of the Leibniz Supercomputing Centre harbours enormous potential for science and industry. The project will contribute to bringing quantum computers close to practice and to provide specific application scenarios for users in science and industry. I am delighted that by launching the project we have reached the first milestone on the way towards a competitive quantum computer 'made in Germany'."
Dr. Jan Goetz, CEO of IQM Quantum Computers remarks: "We are pleased to deliver a quantum computing system to LRZ and to work with the consortium partners to integrate this system into a production-grade HPC environment. I am grateful to the Federal Ministry of Education and Research in Germany, which has given us the necessary trust and support for this ambitious project. Together we will work hard to make European technology competitive and develop the most promising hardware solutions for quantum computing here in Germany".
Prof. Dr. Dieter Kranzlmuller, Chairman of the Board of Directors, LRZ, points out: “The Q-Exa project is key for our activities within the LRZ Quantum Integration Centre (QIC) and the Munich Quantum Valley (MQV). Working with this extremely competitive consortium, we will be able to set European standards that are competitive on a global scale. Ultimately, this will be for the benefit of society as the integration of quantum computing into supercomputers, in particular on the exascale level, will speed up and open vast new research possibilities. It will bring quantum computing to users – both in academia and in industry. And now is exactly the right time to realize this in a data center environment”.
“Technological sovereignty in strategic areas like quantum computing is critical for Europe. With our Quantum Learning Machine (QLM) and strong startup partners like IQM, Atos is proud to contribute to this joint effort. It is time to build the first German quantum computer, connected to an HPC datacenter through our QLM”, says Udo Littke, Head of Atos Central Europe.
„Quantum computers will accelerate scientific progress and the development of new technologies in many areas. Chemistry, physics and biology can potentially profit from the ability to perform improved quantum mechanical simulations. Therefore, it is the next logical step to integrate quantum computers into high performance computer centers like the LRZ. We are looking very much forward to connect the end users of the LRZ with the necessary software tools to make full use of the coming computational capabilities”, says Dr. Michael Marthaler, CEO HQS Quantum Simulations GmbH.
About IQM Quantum Computers:
IQM is the Pan-European category leader in building quantum computers.
IQM delivers on-premises quantum computers for supercomputing centers and research laboratories and provides complete access to its hardware. For industrial customers, IQM delivers quantum advantage through a unique, application-specific, co-design approach.
IQM is building Finland’s first commercial 54-qubit quantum computer with VTT, and an IQM-led consortium was awarded a project to develop application-specific quantum processors by the German Ministry of Education and Research in February 2021.
IQM has raised €71 million from private and public funding and has offices in Munich, Germany; Espoo, Finland; and Bilbao, Spain.
For more information, visit www.meetiqm.com .
IQM: Facts and Figures
- Number of employees currently (November 2021): 130+ employees
- Funding: Over € 71 Million from private and public funding
- Founding Year: 2018
Founders:
-
Dr. Jan Goetz, CEO, Co-founder of IQM
-
Dr. Kuan Yen Tan, CTO, Co-founder of IQM
- Prof. Mikko Mottonen, Chief scientist, Co-founder of IQM
- Dr. Juha Vartiainen, COO, Co-founder of IQM
For more information, visit www.meetiqm.com .
Registered offices:
IQM Finland Oy Keilaranta 19
02150 Espoo Finland
IQM Germany GmbH Nymphenburgerstr. 86 80636 Munchen Germany
View source version on businesswire.com: https://www.businesswire.com/news/home/20211115006110/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE03428.2.2026 01:00:00 CET | Press release
IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and in combination with IDEAYA’s PARG inhibitor IDE161. IDEAYA has dosed the first patient in its Phase 1 trial of IDE034, initially evaluating safety, tolerability, and PK. First dosing triggers a $5 million milestone payment to Biocytogen under the companies’ option and license agreement. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to the companies’ option and license agreement, first patient dosing triggers a $5 million
IQM and Real Asset Acquisition Corp. to Host Conference Call/Webcast to Discuss Proposed Transaction27.2.2026 13:00:00 CET | Press release
IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a special purpose acquisition company (“RAAQ”), announced that they will host a conference call to discuss their recently announced business combination, including certain transaction highlights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227472716/en/ IQM Radiance quantum computer As previously disclosed, on February 23, 2026, IQM and RAAQ announced they have entered into a definitive business combination agreement, which will result in IQM becoming a public company and listing American Depositary Shares on one of the two leading U.S. stock exchanges. The transaction provides funding with the aim to accelerate IQM’s technology and commercial development towards fault-tolerance quantum computing, further advancing its position as a leading p
HighRadius Launches $0 Implementation Fee, $0 Subscription Fee via Outcome Based Pricing for oCFO Software27.2.2026 12:00:00 CET | Press release
HighRadius launches Office of the CFO first Outcome Based Pricing with $0 Implementation fee and $0 Subscription until Go-Live. Customers only pay a fraction of realized gains based on P&L impact. Chapter 1: Outcome Based Pricing (OBP)Introduction of OBP: HighRadius, a provider of 190+ AI agents for Order-to-Cash, Accounts Payable, Record-to-Report, and Treasury introduces Outcome Based Pricing (OBP). Three Components of OBP: Customers pay a) $0 in Implementation fees, b) $0 in Subscription fees until Go Live, c) HighRadius earns a fraction of the actual savings realized by the client. Chapter 2: US GAAP & ASC 606 ConstraintsNot Designed for Innovation: The traditional ASC 606 model requires companies to standardize and recognize revenue based on contractual obligations. For a traditional SaaS subscription, the obligation is access to software over time. AI agents are designed to deliver quantifiable, real-time Business Outcomes that do not fit the traditional accounting framework. Cha
Kioxia Appoints Yoshihiko Kawamura as Chief Financial Officer27.2.2026 09:15:00 CET | Press release
Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced the appointment of Yoshihiko Kawamura as Chief Financial Officer (CFO), effective April 1, 2026. Mr. Kawamura brings extensive international experience to Kioxia, having held assignments at Mitsubishi Corporation’s U.S. headquarters, served as General Manager of its Chicago office, and completed a tenure at the World Bank. At Hitachi, Ltd., he held senior leadership positions, including Chief Strategy Officer (CSO), Chief Financial Officer (CFO), and Chief Risk Management Officer (CRMO), where he was instrumental in leading the company’s management reforms. Since joining Kioxia as Executive Vice President in June 2025, Mr. Kawamura has worked closely with the executive team to advance the business through strategic capital and financial planning. Following its initial public offering on the Prime Market of the Tokyo Stock Exchange in December 2024, Kioxia is entering a new phase of growth char
DNP Invests in Rapidus to Support the Establishment of Mass Production for Next-Generation Semiconductors27.2.2026 08:18:00 CET | Press release
Will accelerate the development and mass production of EUV lithography photomasks Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912) today announced that it has participated in Rapidus Corporation’s funding round as one of the round investors. This strategic funding initiative supports Rapidus’ plan to steadily progress from its current R&D phase to mass production of 2nm (10⁻⁹ meters) logic semiconductors by 2027. Through this initiative, DNP will advance the development and mass production of EUV lithography photomasks and support Rapidus as it establishes a mass production system for 2nm & next-generation semiconductors. Background In recent years, the rise in energy consumption, in line with increased data generation, has become a challenge, driving demand for next-generation semiconductors capable of improving device performance and reducing power consumption. Next-generation semiconductors manufactured using EUV lithography enable the formation of finer patterns on silicon wafers co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom